Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/is-the-market-bottom-in-analysts-predict-a-recovery-could-be-bigger-than-expected/